Press release
Key Trends Influencing the Growth of the Healthcare CRO Services Market in 2025: Strategic Partnerships Drive Progress In The Healthcare CRO Services Market
Healthcare CRO Services
What Is the Expected CAGR for the Healthcare CRO Services Market Through 2025?
In recent times, the healthcare CRO services market has witnessed robust growth. The market, valued at $62.01 billion in 2024, is expected to rise to $66.97 billion in 2025, resulting from a compound annual growth rate (CAGR) of 8.0%. The significant growth observed in the historic period can be related to the enhanced focus on regulatory and medical affairs services by CROs, the internationalization of clinical trials, the increasing intricacy of these trials, digital transitions within clinical trials, and a rise in chronic diseases.
What's the Projected Size of the Global Healthcare CRO Services Market by 2029?
The healthcare CRO services market is projected to witness substantial growth in the upcoming years, escalating to $95.99 billion by 2029 with a compound annual growth rate (CAGR) of 9.4%. This predicted growth during the forecasted period can be credited to the emergence of cell and gene therapies, increased focus on rare diseases and cost-effectiveness, expanding need for real-world data, patient-centric medical engagement, and the growth of the biopharmaceutical pipeline. The forecasted period is also set to feature significant trends such as the incorporation of artificial intelligence (AI) and machine learning (ML), Environmental, Social, and Governance (ESG) considerations, and escalating research and development investments by pharmaceutical firms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report
Top Growth Drivers in the Healthcare CRO Services Industry: What's Accelerating the Market?
The escalation in costs related to healthcare is anticipated to stimulate the expansion of the healthcare CRO services market in the future. Healthcare expenditures encompass all expenses tied to delivering health services, family planning measures, nutrition schemes, and emergency assistance with a focus on health concerns. A surge in healthcare spending creates a larger funding pool for medical research and development, thus driving demand for healthcare CRO services and their role in facilitating clinical trials and research. In 2022, for example, the Office for National Statistics, a UK-based statistics organisation focused on epilepsy, reported the UK healthcare expenditure at around $354.88 billion (£283 billion), displaying a modest increase of 0.7% compared to 2021 spending. Hence, the expansion in healthcare costs is fuelling the growth of the healthcare CRO services market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12136&type=smp
What Trends Will Shape the Healthcare CRO Services Market Through 2029 and Beyond?
Leading firms in the healthcare CRO services market are adopting strategic partnerships as a means of providing advanced Proteomics CRO services to global biopharmaceutical and biomarker clients. This kind of partnership allows companies to utilize each other's resources and strengths for mutual profit and success. For example, in January 2023, Bruker Corporation, an American scientific instruments manufacturer, formed a collaboration with Biognosys AG, a Swiss healthcare CRO services provider. The partnership between Bruker and Biognosys is expected to create unique synergies by taking advantage of Biognosys' wide array of proprietary proteomics services, software, and kits, backed up by Bruker's pioneering timsTOF platform. This strategic collaboration is poised to establish the first Biognosys' laboratory for advanced proteomics CRO services in the United States.
What Are the Main Segments in the Healthcare CRO Services Market?
The healthcare CRO services market covered in this report is segmented -
1) By Service Type: Early Phase Development, Clinical Development Services, Laboratory Services, Consulting Services
2) By Therapeutic Area: Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Diabetes, Other Therapeutic Areas
3) By End User: Pharmaceutical Companies, Medical Device Companies, Academic Institutes
Subsegments:
1) By Early Phase Development: Preclinical Studies, Phase I Trials, Formulation Development
2) By Clinical Development Services: Phase II Trials, Phase III Trials, Patient Recruitment And Retention, Site Management
3) By Laboratory Services: Bioanalytical Testing, Clinical Laboratory Services, Safety And Toxicology Testing
4) By Consulting Services: Regulatory Affairs Consulting, market Access And Commercialization, Strategic Planning And Feasibility Studies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12136&type=smp
Which Top Companies are Driving Growth in the Healthcare CRO Services Market?
Major companies operating in the healthcare CRO services market include Laboratory Corporation of America Holdings., IQVIA Inc., Icon Plc., PPD Inc., Wuxi Apptec Co. Ltd., Syneos Health Inc., Parexel International Corporation, Charles River Laboratories International Inc., Covance Inc., Medpace Inc., Pharmaron Beijing Co. Ltd., BioClinica Inc., Chiltern International Ltd., Evotec SE, PSI CRO AG, Premier Research Group Ltd., Worldwide Clinical Trials Inc., Caidya, BioTelemetry Inc., Syngene International Limited, Novotech CRO, Celerion, GVK Biosciences Private Limited, Synteract Inc., Veristat LLC., ACM Global Laboratories, ClinTec Luxembourg SA, Clinlogix LLC
Which Regions Will Dominate the Healthcare CRO Services Market Through 2029?
North America was the largest region in the healthcare CRO services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare CRO services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12136
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trends Influencing the Growth of the Healthcare CRO Services Market in 2025: Strategic Partnerships Drive Progress In The Healthcare CRO Services Market here
News-ID: 4099114 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for CRO
Contract Research Organization (CRO) Research: China CRO market size is projecte …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Contract Research Organization (CRO)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few…
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028.
The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used…
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028.
The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug…
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630
This latest report…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer.
Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues…
